NFKB1 and diffuse large B-cell lymphoma: Since the NF-κB pathway has a well-known oncogenic potential in ABC-type nodal DLBCL [47], it can be speculated that downregulation of miR-9-5p might have a pathogenic effect in PCLBCL-LT through reduced inhibition of NF-κB signaling.